Elevated blood IGFBP2 level has been identified in various human malignancies such as ovarian cancer [16], prostate cancer [20], lung cancer [18], pancreatic cancer [21], glioma [22] and colon cancer [17]. This evidence concerns the gene IGFBP2 and ovarian cancer.